Your browser is no longer supported. Please, upgrade your browser.
Settings
AMRN Amarin Corporation plc daily Stock Chart
AMRN [NASD]
Amarin Corporation plc
Index- P/E- EPS (ttm)-0.37 Insider Own3.93% Shs Outstand176.27M Perf Week0.40%
Market Cap444.20M Forward P/E- EPS next Y-0.14 Insider Trans0.00% Shs Float149.51M Perf Month3.70%
Income-62.40M PEG- EPS next Q-0.12 Inst Own36.90% Short Float15.52% Perf Quarter6.78%
Sales59.20M P/S7.50 EPS this Y68.90% Inst Trans-18.37% Short Ratio10.02 Perf Half Y157.22%
Book/sh-0.50 P/B- EPS next Y70.20% ROA-32.20% Target Price8.00 Perf Year45.66%
Cash/sh0.91 P/C2.76 EPS next 5Y- ROE84.60% 52W Range0.78 - 3.33 Perf YTD157.22%
Dividend- P/FCF- EPS past 5Y15.00% ROI-37.80% 52W High-24.32% Beta0.93
Dividend %- Quick Ratio4.10 Sales past 5Y- Gross Margin63.00% 52W Low223.08% ATR0.14
Employees201 Current Ratio4.50 Sales Q/Q44.50% Oper. Margin- RSI (14)60.34 Volatility5.80% 4.89%
OptionableYes Debt/Eq- EPS Q/Q-20.00% Profit Margin- Rel Volume0.70 Prev Close2.45
ShortableYes LT Debt/Eq- EarningsAug 06 AMC Payout- Avg Volume2.32M Price2.52
Recom2.00 SMA203.73% SMA5014.39% SMA20058.78% Volume1,632,718 Change2.86%
Mar-12-15Upgrade H.C. Wainwright Neutral → Buy $2.50 → $10
Apr-01-14Reiterated MKM Partners Neutral $1.50 → $2
Feb-24-14Reiterated MKM Partners Neutral $2.50 → $1.75
Jan-16-14Downgrade MKM Partners Buy → Neutral $2.50
Nov-08-13Reiterated MKM Partners Buy $5 → $2.50
Oct-30-13Initiated FBR Capital Mkt Perform $2
Oct-17-13Reiterated MKM Partners Buy $9 → $5
Oct-17-13Downgrade Canaccord Genuity Buy → Hold $10 → $3
Oct-17-13Downgrade Aegis Capital Buy → Hold
Mar-20-13Initiated Chardan Capital Markets Hold $8.50
Dec-10-12Reiterated Aegis Capital Buy $25 → $35
Dec-07-12Reiterated Aegis Capital Buy $25 → $35
Jul-12-11Initiated MKM Partners Buy $23
Apr-25-11Reiterated Wedbush Outperform $12 → $18
Apr-18-11Reiterated Canaccord Genuity Buy $11 → $18
Dec-29-10Reiterated Wedbush Outperform $7 → $10
Jul-20-10Initiated Wedbush Outperform $5
Feb-03-09Initiated Rodman & Renshaw Mkt Outperform $3.50
Nov-06-08Initiated Rodman & Renshaw Mkt Outperform $3.50
Jun-11-15 07:00AM  New In Vitro Eicosapentaenoic Acid Study Data to Be Presented at the National Lipid Association Scientific Sessions in Chicago Marketwired
Jun-08-15 07:00AM  New In Vitro Eicosapentaenoic Acid Study Data Presented June 6 at the American Diabetes Association Scientific Sessions in Boston Marketwired
Jun-03-15 03:40PM  Matinas and Amarin's Destinies are Linked as MAT9001 Outshines Vascepa Accesswire +5.65%
May-29-15 04:43PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events
08:37AM  Amarin (AMRN) in Focus: Stock Surges 19% in Session - Tale of the Tape
07:20AM  What Biotechnology Stocks Will Be Next To Enjoy The Bull Market? Accesswire
May-28-15 03:46PM  Amarin's Lawsuit Could Have Huge Benefits For Pharma Industry And Dire Consequences For Consumers at Forbes +18.97%
02:29PM  Amarin Granted Summary Judgment Motion in Suit Against FDA Seeking New Chemical Entity Market Exclusivity for Vascepa(R) (Icosapent Ethyl) Capsules Marketwired
02:26PM  U.S. court grants exclusivity for Amarin's Vascepa
May-26-15 05:00PM  Amarin to Present at the Jefferies 2015 Global Healthcare Conference Marketwired
May-18-15 08:31AM  Why Amarin Corporation (AMRN) Could Be Positioned for a Slump - Tale of the Tape
May-15-15 01:04PM  AMARIN CORP PLC\UK Financials
May-08-15 08:16AM  Secret Letter To Doctors Shows That The Amarin Lawsuit Is About Marketing, Not Free Speech at Forbes -6.57%
07:07AM  Q1 2015 Amarin Corporation PLC Earnings Release - Before Market Open
06:19AM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
06:00AM  Amarin Reports First Quarter 2015 Financial Results and Provides Update on Operations Marketwired
May-07-15 09:11PM  Drug Firms Challenge FDA Over Free Speech at The Wall Street Journal
05:52PM  Irish drugmaker sues FDA under First Amendment Reuters
04:59PM  Amarin sues U.S. FDA on free speech grounds over off-label speech Reuters
04:50PM  Prescription Fish Oil Maker Hires Top Lawyer To Sue FDA On First Amendment Grounds at Forbes
04:10PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events
04:05PM  Amarin to Host First Quarter 2015 Earnings Conference Call and Webcast Live on Friday, May 8, 2015 Accesswire
May-05-15 06:34PM  Amarin to Report First Quarter 2015 Results and Host Conference Call on May 8, 2015 at noodls
05:00PM  Amarin to Report First Quarter 2015 Results and Host Conference Call on May 8, 2015 Marketwired
Apr-28-15 11:09AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amarin Corporation AMRN Accesswire
06:32AM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events
Apr-09-15 08:55AM  How Amarin Corporation (AMRN) Stock Stands Out in a Strong Industry - Tale of the Tape
Apr-08-15 08:26AM  Amarin and Non-Profit, Walk with a Doc Partner to Expand National Health Awareness Efforts at noodls
08:00AM  Amarin and Non-Profit, Walk with a Doc Partner to Expand National Health Awareness Efforts Marketwired
Mar-30-15 04:32PM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securi
Mar-16-15 05:44PM  Amarin, LeapFrog Lead Monday's After-Hours Movers
05:10PM  New In Vitro Study Presented at the American College of Cardiology Meeting Suggests Omega-3 Fatty Acid EPA Pre-Treatment Reduces Oxidative Damage and May Provide Atheroprotective Benefit Versus Other Triglyceride Lowering Agents at noodls
04:30PM  New In Vitro Study Presented at the American College of Cardiology Meeting Suggests Omega-3 Fatty Acid EPA Pre-Treatment Reduces Oxidative Damage and May Provide Atheroprotective Benefit Versus Other Triglyceride Lowering Agents Marketwired
Mar-14-15 09:20AM  8 Analyst Stocks Under $10 With Massive Upside Calls at 24/7 Wall St.
Mar-13-15 03:06PM  3 Biotech Stocks on Traders' Radars: Technical Charts at TheStreet +21.85%
09:00AM  Biotech Stock Mailbag: Neuralstem, Genfit, Intercept, Amarin at TheStreet
Mar-12-15 08:20AM  Top Analyst Upgrades and Downgrades: Amarin, CONSOL, Garmin, GNC, HP, Peabody, Windstream and More at 24/7 Wall St. +22.68%
07:10AM  Amarin upgraded by H.C. Wainwright
Mar-11-15 06:01PM  Wednesday's After-Hours Movers: Shake Shack, Box And Others Fall Following Earnings
08:02AM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securi
Mar-06-15 05:10AM  Amarin Announces $52.8 Million Private Placement at noodls +6.59%
05:00AM  Amarin Announces $52.8 Million Private Placement Marketwired
Mar-04-15 08:12AM  New In Vitro Study Presented at DEUEL Conference on Lipids Suggests Combination Omega-3 Fatty Acid EPA and Atorvastatin May Provide Atheroprotective Benefit at noodls +9.74%
08:00AM  New In Vitro Study Presented at DEUEL Conference on Lipids Suggests Combination Omega-3 Fatty Acid EPA and Atorvastatin May Provide Atheroprotective Benefit Marketwired
Mar-03-15 04:27PM  Amarin to Report Fourth Quarter and Year-End 2014 Results and Host Conference Call on March 3, 2015 at noodls
04:27PM  Amarin to Host Fourth Quarter and Fiscal Year 2014 Earnings Conference Call and Webcast Live on Tuesday, March 3, 2015 at noodls
04:27PM  Amarin Reports Fourth Quarter and Year-End 2014 Financial Results and Provides Update on Operations at noodls
04:00PM  Amarin Reports Fourth Quarter and Year-End 2014 Financial Results and Provides Update on Operations Marketwired
Mar-02-15 04:05PM  Amarin to Host Fourth Quarter and Fiscal Year 2014 Earnings Conference Call and Webcast Live on Tuesday, March 3, 2015 Accesswire
01:00PM  What's in Store for Geron (GERN) this Earnings Season? - Analyst Blog Zacks
Feb-28-15 08:01PM  Intercept Pharmaceuticals (ICPT): Will It Miss Q4 Earnings? - Analyst Blog Zacks
Feb-27-15 04:22PM  Will Arena Pharmaceuticals (ARNA) Disappoint on Q4 Earnings? - Analyst Blog Zacks
04:18PM  Will Endo Internationa's (ENDP) Beat on Earnings in Q4? - Analyst Blog Zacks
01:30PM  Will Mylan (MYL) Beat Earnings on New Product Launches? - Analyst Blog Zacks
11:10AM  Will Stratasys (SSYS) Disappoint this Earnings Season? - Analyst Blog Zacks
Feb-26-15 10:50AM  What Awaits Keryx Biopharmaceuticals (KERX) this Earnings? - Analyst Blog Zacks +5.04%
09:16AM  Amarin and Eddingpharm Announce Agreement to Develop and Commercialize Vascepa(R) (icosapent ethyl) in China Marketwired
Feb-25-15 11:00AM  Will Epizyme (EPZM) Miss Estimates This Earnings Season? - Analyst Blog Zacks
08:45AM  Should You Buy Amarin Corporation (AMRN) Ahead of Earnings? - Tale of the Tape Zacks
Feb-24-15 04:10PM  Merrimack Pharmaceuticals (MACK): A Miss this Earnings? - Analyst Blog Zacks
03:40PM  Will Aegerion (AEGR) Miss Earnings Estimates This Season? - Analyst Blog Zacks
01:50PM  Will Ingram Micro (IM) Miss Earnings Estimates in Q4? - Analyst Blog Zacks
12:40PM  What's in Store for OmniVision (OVTI) This Earnings? - Analyst Blog Zacks
Feb-23-15 04:30PM  Amarin to Report Fourth Quarter and Year-End 2014 Results and Host Conference Call on March 3, 2015 Marketwired +6.77%
09:13AM  Can The Uptrend Continue for Amarin (AMRN)? - Tale of the Tape Zacks
Feb-10-15 02:01PM  4 Biotech Stocks Under $10 Triggering Breakouts: Amarin, Exelixis and More at TheStreet
Jan-12-15 08:01AM  AMARIN CORP PLC\UK Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
Jan-05-15 07:00AM  Amarin to Present at the 33rd Annual J.P. Morgan Healthcare Conference Marketwired -6.19%
Dec-04-14 07:00AM  Amarin to Present at the 25th Annual Oppenheimer Healthcare Conference Marketwired
Nov-19-14 06:12AM  Amarin Corporation plc (AMRN) in Focus: Stock Soars 23.4% Zacks -5.30%
Nov-17-14 09:00AM  Amarin Announces Presentation of MARINE and ANCHOR Analyses at the American Heart Association Scientific Sessions Showing Vascepa(R) Significantly Reduced Remnant-Like Particle Cholesterol in Hypertriglyceridemic Patients Marketwired +12.66%
Nov-14-14 04:43PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events EDGAR Online
Nov-13-14 07:00AM  Rick Harrison of Television's "Pawn Stars(R)" Takes His Patient-Care Message to AHA Scientific Sessions to Raise Awareness of Very High Triglycerides as Part of National Campaign Marketwired +6.98%
Nov-06-14 04:02PM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
04:00PM  Amarin Reports Third Quarter 2014 Financial Results and Provides Update on Operations Marketwired
07:07AM  Q3 2014 Amarin Corporation PLC Earnings Release - After Market Close CCBN
Nov-05-14 04:45PM  Amarin to Host Third Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, November 6, 2014 Accesswire +6.39%
Oct-30-14 07:00AM  Amarin to Report Third Quarter 2014 Results and Host Conference Call on November 6, 2014 Marketwired
Oct-16-14 08:01AM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financia EDGAR Online +6.06%
Sep-16-14 06:07AM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events EDGAR Online
01:00AM  Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study Marketwired
Sep-15-14 03:45PM  Amarin Plunges after the FDA Denies Vascepa SPA Appeal Zacks
Sep-12-14 04:51PM  Week Concludes With S&P 500 Below 2,000; Dow Below 17,000 Benzinga -17.68%
03:59PM  Dow Falls Over 100 Points; Ulta Salon Shares Jump After Earnings Report Benzinga
02:02PM  Conversant Shares Rise On Acquisition News; Health Care REIT Drops Benzinga
11:39AM  Why Amarin (AMRN) Stock Is Plummeting Today at TheStreet
11:26AM  Markets Drop; Darden Adjusted Profit Beats Street View Benzinga
09:43AM  Third Time Was No Charm, FDA Denies Amarin Vascepa SPA Appeal at TheStreet
09:00AM  Amarin Provides Update on ANCHOR Trial SPA Agreement Rescission Appeal Marketwired
Sep-09-14 11:47AM  Notice to Investors in Amarin Corp. plc's (AMRN) July 10, 2013 Public Offering: Wolf Popper LLP Announces Anticipated Filing of Amended Complaint Against Amarin Corp. plc (NASDAQ: AMRN) PR Newswire
Sep-03-14 07:00AM  Amarin to Present at the Rodman & Renshaw 2014 Global Investment Conference Marketwired
06:45AM  Is Amarin Corporation (AMRN) Stock a Solid Choice Right Now? Zacks
Aug-07-14 04:18PM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
04:01PM  Amarin Reports Second Quarter 2014 Financial Results and Provides Update on Operations Marketwired
Aug-05-14 07:00AM  Amarin to Report Second Quarter 2014 Results and Host Conference Call on August 7, 2014 Marketwired
Jul-31-14 12:01PM  Amarin Moves Higher On Speculation Of Special Protocol Assessment Benzinga +13.21%
09:02AM  Amarin Shocker: There's a Reason to be Bullish Right Now at TheStreet
Jul-21-14 04:38PM  Amarin: Will The Lamb Of Ireland Bleat Or The Lion Of The People Roar? at Seeking Alpha
Jul-10-14 04:31PM  AMARIN CORP PLC\UK Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Jun-27-14 08:35AM  Amarin Scrapes The Bottom Of The Barrel at Seeking Alpha
Amarin Corporation plc, a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product includes Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.